CN Stock MarketDetailed Quotes
002589 Realcan Pharmaceutical Group
- 2.37
- +0.07+3.04%
Market Closed Sep 19 15:00 CST
3.57BMarket Cap169.29P/E (TTM)
2.38High2.30Low185.64KlotVolume2.31Open2.30Pre Close43.58MTurnover1.36%Turnover Ratio169.29P/E (Static)1.50BShares3.7552wk High0.65P/B3.24BFloat Cap2.0452wk Low2.53Limit Up1.37BShs Float23.92Historical High2.07Limit Down3.48%Amplitude1.90Historical Low0.01Dividend TTM2.35Avg Price65.45KlotAsk0.55%Div YieldTTM100Lot Size116.33KlotBid
Realcan Pharmaceutical Group Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -34.60%4.04B | -41.63%4.02B | -5.23%5.06B | -3.59%5.53B | 14.92%6.18B | 38.07%6.89B | 16.63%5.34B | 7.89%5.73B | 6.86%5.38B | -16.72%4.99B |
| Transactional financial assets | ---- | ---- | ---- | 600.00%70M | --120M | --100M | ---- | 9.89%10M | ---- | ---- |
| Notes receivable and accounts receivable | 7.62%4.51B | -3.60%4.17B | -7.75%3.98B | -50.09%4.17B | -58.06%4.19B | -63.34%4.33B | -60.81%4.31B | -33.20%8.35B | -23.00%10B | -19.65%11.81B |
| -Notes receivable | 167.67%600.58M | 1.89%223.15M | 7.36%217.04M | -39.60%260.62M | -60.04%224.37M | -84.96%219.02M | -72.03%202.16M | -49.59%431.46M | -35.42%561.56M | -8.34%1.46B |
| -Accounts receivable | -1.43%3.91B | -3.90%3.95B | -8.50%3.76B | -50.66%3.91B | -57.95%3.97B | -60.29%4.11B | -60.02%4.11B | -32.00%7.92B | -22.11%9.44B | -21.02%10.35B |
| Other receivables (including interest and dividends) | -24.95%927.41M | -29.02%968.76M | -40.73%990.01M | -40.88%1.14B | -36.68%1.24B | -27.20%1.36B | -11.93%1.67B | -0.32%1.93B | -9.36%1.95B | 11.57%1.87B |
| -Other receivable | -24.95%927.41M | ---- | -40.73%990.01M | ---- | -36.68%1.24B | ---- | -11.93%1.67B | ---- | -9.35%1.95B | ---- |
| Advance payment | 46.04%201.04M | -5.84%156.33M | -49.18%97.37M | -77.63%104.45M | -79.31%137.66M | -78.78%166.03M | -70.11%191.59M | -30.11%466.85M | -11.20%665.48M | -12.27%782.41M |
| Inventories | 5.68%926.48M | 27.17%978.04M | 17.24%1.12B | -43.88%788.33M | -48.77%876.69M | -59.21%769.07M | -53.84%954.51M | -35.42%1.4B | -28.94%1.71B | -28.96%1.89B |
| Receivable financing | -58.38%151.63M | -51.39%130.83M | -16.24%242.01M | 3.33%295.58M | 39.11%364.3M | 17.16%269.15M | 7.88%288.92M | 23.40%286.04M | 22.12%261.89M | 10.16%229.74M |
| Other current assets | -34.08%46.76M | -5.06%53.46M | -16.13%49.81M | -9.61%49.86M | 11.07%70.93M | -60.08%56.31M | -59.08%59.39M | -59.24%55.16M | -52.08%63.86M | -8.28%141.04M |
| Total current assets | -17.99%10.81B | -24.83%10.48B | -9.99%11.54B | -33.61%12.14B | -34.42%13.18B | -35.97%13.95B | -37.99%12.82B | -20.89%18.29B | -15.62%20.09B | -17.67%21.78B |
| Non Current assets | ||||||||||
| Other equity investment | -65.71%5.22M | -65.71%5.22M | -65.71%5.22M | -65.71%5.22M | 0.00%15.22M | 0.00%15.22M | 0.00%15.22M | 188.89%15.22M | 188.89%15.22M | 188.89%15.22M |
| Other non-current financial assets | 33.96%191.42M | 33.96%191.42M | 33.96%191.42M | 20.49%142.9M | 19.88%142.9M | 6.05%142.9M | -5.89%142.9M | -17.12%118.6M | -16.70%119.2M | -5.84%134.75M |
| Investment real estate | -5.22%595.61M | -1.27%600.44M | -3.22%605.26M | 3.06%610.22M | 2.05%628.38M | -4.96%608.14M | -2.93%625.42M | 22.70%592.08M | 52.66%615.78M | 441.54%639.9M |
| Long-term equity investment | 22.57%534.36M | 54.10%671.81M | 50.34%655.39M | 1.11%714.13M | -43.53%435.95M | -41.17%435.95M | -31.75%435.95M | -27.67%706.29M | -20.53%772.03M | -18.61%741.08M |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -90.08%66.1K |
| Fixed assets | -1.52%1.96B | ---- | -6.57%1.85B | ---- | 11.31%1.99B | ---- | 2.78%1.98B | ---- | -15.87%1.78B | ---- |
| Constru in process | -15.03%279.68M | ---- | 36.14%429.34M | ---- | -49.46%329.13M | ---- | -42.62%315.37M | ---- | 16.93%651.23M | ---- |
| Productive biological assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%713.39K | 0.00%713.39K |
| Oil and gas assets | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Intangible assets | -12.76%516.58M | -14.41%531.29M | -11.51%552.39M | 16.81%582.44M | 19.42%592.17M | 31.11%620.72M | 30.49%624.21M | 46.84%498.63M | 45.61%495.87M | 40.80%473.44M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | 0.00%9.58M | 0.00%9.58M | 0.00%9.58M |
| Goodwill | -0.01%146.67M | -0.01%146.67M | -0.01%146.67M | -71.55%146.69M | -75.19%146.69M | -76.35%146.69M | -76.35%146.69M | -26.71%515.65M | -16.24%591.18M | -22.90%620.27M |
| Long deferred expense | -41.56%45.98M | -43.89%50.03M | -32.32%60.87M | -38.75%71.01M | -28.73%78.68M | -32.62%89.16M | -28.06%89.93M | -13.28%115.94M | -18.09%110.4M | -9.35%132.33M |
| Deferred tax assets | 249.89%283.71M | 137.80%243.38M | 166.64%284.44M | -16.61%98.97M | -32.77%81.08M | -13.63%102.35M | -13.17%106.68M | -0.37%118.68M | 5.06%120.6M | 25.90%118.5M |
| Usufruct assets | 59.33%5.73M | 37.02%6.54M | -60.95%2.52M | -91.23%2.75M | -92.09%3.6M | -89.68%4.77M | -88.28%6.45M | -41.92%31.36M | -24.28%45.52M | --46.28M |
| Other non current assets | -46.16%357.43M | -54.61%385.44M | -61.97%391.13M | 76.29%633.79M | 84.82%663.93M | 111.00%849.17M | 163.13%1.03B | 276.74%359.52M | 264.05%359.23M | 159.18%402.44M |
| Total non current assets | -3.63%4.92B | -3.20%5.07B | -6.21%5.17B | -3.90%5.28B | -10.31%5.1B | -8.70%5.24B | -3.71%5.51B | -4.29%5.5B | 0.44%5.69B | -2.81%5.74B |
| Total assets | -13.98%15.73B | -18.92%15.56B | -8.85%16.71B | -26.74%17.43B | -29.10%18.28B | -30.28%19.19B | -30.55%18.33B | -17.58%23.79B | -12.54%25.78B | -14.96%27.52B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 30.48%5.53B | -12.40%4.8B | 70.74%6.56B | -32.50%3.7B | -25.32%4.24B | 11.69%5.48B | -7.81%3.84B | -20.93%5.48B | -28.10%5.68B | -44.34%4.91B |
| Notes payable and accounts payable | -49.55%3.68B | -39.30%4.23B | -51.75%3.72B | -8.84%7.06B | -11.87%7.29B | -28.35%6.98B | -21.21%7.71B | 1.48%7.74B | 16.07%8.27B | 9.11%9.74B |
| -Notes payable | -79.35%1.02B | -67.37%1.51B | -91.30%448.6M | 6.68%4.85B | -2.63%4.93B | -25.66%4.62B | -19.86%5.16B | 13.40%4.55B | 57.38%5.06B | 40.81%6.21B |
| -Accounts payable | 12.64%2.66B | 15.68%2.73B | 28.02%3.27B | -30.93%2.21B | -26.43%2.36B | -33.09%2.36B | -23.78%2.56B | -11.72%3.2B | -17.91%3.21B | -21.89%3.52B |
| Contract liabilities | -13.81%27.31M | -57.76%17.54M | -8.45%29.12M | -74.09%28.26M | -72.97%31.68M | -64.73%41.53M | -81.80%31.8M | -32.61%109.07M | -27.20%117.21M | -38.43%117.76M |
| Advance receipts | ---- | --0 | ---- | ---- | ---- | ---- | --627.17K | ---- | ---- | ---- |
| Salaries payable | -1.08%18.1M | -17.47%17.87M | -20.92%17.91M | -49.18%17.14M | -53.01%18.3M | -40.15%21.65M | -59.41%22.65M | -17.10%33.73M | -6.19%38.94M | -31.57%36.17M |
| Taxs payable | 13.71%19.77M | -64.05%16.17M | -48.55%14.78M | -84.45%17.14M | -86.76%17.39M | -76.10%44.99M | -84.97%28.73M | -42.38%110.21M | -32.90%131.39M | -17.82%188.25M |
| Other payable (including interest and dividends) | -56.47%278.42M | -46.71%368.69M | -56.68%316.91M | -57.26%606M | -58.31%639.65M | -57.20%691.81M | -58.55%731.62M | -35.85%1.42B | -34.38%1.53B | -22.93%1.62B |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Dividend payable | -89.37%3.94M | -94.12%3.94M | -94.12%3.94M | -93.97%22.09M | -90.64%37.09M | -87.12%67.09M | -87.12%67.09M | 260.96%366.6M | 514.09%396.34M | 27,990.85%520.72M |
| -Other payable | -54.45%274.47M | ---- | -52.90%312.97M | ---- | -47.05%602.56M | ---- | -46.60%664.53M | ---- | -49.95%1.14B | ---- |
| Non current liabilities due within one year | -72.45%3.05M | 694.15%8.99M | -26.50%6.12M | 190.81%10.51M | 132.55%11.08M | -81.75%1.13M | -49.17%8.33M | -42.66%3.61M | -26.70%4.76M | 417.25%6.21M |
| Other current liabilities | 10.19%99.71M | 60.97%115.73M | 8.32%97.59M | -56.67%79.57M | -61.52%90.49M | -93.30%71.89M | -69.72%90.09M | -85.77%183.65M | -82.45%235.16M | 4.70%1.07B |
| Total current liabilities | -21.73%9.65B | -28.13%9.58B | -13.69%10.76B | -23.66%11.52B | -22.96%12.33B | -24.79%13.33B | -24.47%12.47B | -18.59%15.09B | -16.62%16.01B | -17.38%17.73B |
| Current liabilities | ||||||||||
| Long term loan | 177.94%326.85M | 982.33%269.5M | 288.80%261.27M | 129.86%176.3M | 64.48%117.6M | -65.89%24.9M | 38.56%67.2M | 53.40%76.7M | --71.5M | 1,023.08%73M |
| Deferred tax liabilities | 25.29%46.16M | 19.18%45.79M | 17.01%47.48M | 26.77%35.78M | 24.84%36.84M | -54.02%38.42M | -51.44%40.58M | -81.05%28.23M | -80.19%29.51M | -55.79%83.56M |
| Long term deferred income | -11.73%1.55M | -15.09%1.59M | -16.28%1.62M | -26.99%1.75M | -89.91%1.76M | -89.31%1.87M | -88.95%1.93M | -88.03%2.39M | -13.22%17.41M | -13.77%17.47M |
| Lease liabilities | 264.66%4.54M | 53.37%4.64M | -69.39%835.71K | -95.93%1.06M | -96.50%1.25M | -92.04%3.03M | -93.03%2.73M | -50.63%26.09M | -40.75%35.62M | --38.03M |
| Other non current liabilities | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --12.71M | --7.41M | -91.80%7.28M |
| Total non current liabilities | 140.79%379.11M | 371.32%321.52M | 176.77%311.21M | 47.07%214.89M | -2.48%157.45M | -68.90%68.22M | -42.64%112.44M | -46.24%146.12M | -30.18%161.46M | -36.37%219.34M |
| Total liabilities | -19.68%10.03B | -26.09%9.9B | -11.99%11.07B | -22.98%11.73B | -22.75%12.49B | -25.33%13.4B | -24.68%12.58B | -18.99%15.23B | -16.79%16.17B | -17.68%17.95B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B |
| Capital reserve funds | 1.86%3.59B | 0.30%3.72B | 0.52%3.72B | 4.82%3.53B | -7.95%3.52B | -2.42%3.71B | -7.83%3.7B | -16.31%3.36B | -4.85%3.82B | -3.33%3.8B |
| Surplus reserve funds | 4.42%159.53M | 4.42%159.53M | 4.42%159.53M | 0.00%152.77M | 0.00%152.77M | 0.00%152.77M | 0.00%152.77M | 13.41%152.77M | 13.41%152.77M | 13.41%152.77M |
| Retained profit | -1.69%305.76M | 2.64%309.47M | 5.15%294.3M | -86.21%299.57M | -85.76%311.01M | -86.09%301.51M | -86.83%279.89M | 1.55%2.17B | 2.55%2.18B | -0.28%2.17B |
| Less:Treasury stock | --57.65M | 0.00%230.65M | 0.00%230.65M | ---- | ---- | 0.00%230.65M | 0.00%230.65M | 0.00%230.65M | 0.00%230.65M | 0.00%230.65M |
| Shareholders equity without minority interests | 0.17%5.5B | 0.48%5.46B | 0.75%5.45B | -21.26%5.48B | -26.18%5.49B | -26.48%5.44B | -28.54%5.41B | -7.98%6.96B | -1.62%7.44B | -1.58%7.4B |
| Minority interests | -35.33%195.23M | -45.42%192.59M | -45.00%189.18M | -86.66%212.6M | -86.14%301.9M | -83.83%352.84M | -83.82%344M | -36.13%1.59B | -12.52%2.18B | -28.43%2.18B |
| Total shareholder equity | -1.68%5.69B | -2.32%5.66B | -1.99%5.64B | -33.44%5.7B | -39.77%5.79B | -39.55%5.79B | -40.67%5.75B | -14.96%8.56B | -4.32%9.61B | -9.33%9.58B |
| Total liabilityies and equity | -13.98%15.73B | -18.92%15.56B | -8.85%16.71B | -26.74%17.43B | -29.10%18.28B | -30.28%19.19B | -30.55%18.33B | -17.58%23.79B | -12.54%25.78B | -14.96%27.52B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | ZTE Finance Guanghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianyuan Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data